Short-Acting Insulin Market is segmented By Type (Insulin Lispro, Insulin Aspart, Insulin Glulisine), By Indication (Type 1 Diabetes, Type 2 Diabetes), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.